Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection.

Pizzo PA, Eddy J, Falloon J, Balis FM, Murphy RF, Moss H, Wolters P, Brouwers P, Jarosinski P, Rubin M, et al.

N Engl J Med. 1988 Oct 6;319(14):889-96.

PMID:
3166511
2.

A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study Group.

McKinney RE Jr, Maha MA, Connor EM, Feinberg J, Scott GB, Wulfsohn M, McIntosh K, Borkowsky W, Modlin JF, Weintrub P, et al.

N Engl J Med. 1991 Apr 11;324(15):1018-25.

3.

Effect of continuous-infusion zidovudine therapy on neuropsychologic functioning in children with symptomatic human immunodeficiency virus infection.

Brouwers P, Moss H, Wolters P, Eddy J, Balis F, Poplack DG, Pizzo PA.

J Pediatr. 1990 Dec;117(6):980-5.

PMID:
2246704
4.

The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.

Richman DD, Fischl MA, Grieco MH, Gottlieb MS, Volberding PA, Laskin OL, Leedom JM, Groopman JE, Mildvan D, Hirsch MS, et al.

N Engl J Med. 1987 Jul 23;317(4):192-7.

PMID:
3299090
5.

The pharmacokinetics of zidovudine administered by continuous infusion in children.

Balis FM, Pizzo PA, Murphy RF, Eddy J, Jarosinski PF, Falloon J, Broder S, Poplack DG.

Ann Intern Med. 1989 Feb 15;110(4):279-85.

PMID:
2643914
6.

Safety and tolerance of intermittent intravenous and oral zidovudine therapy in human immunodeficiency virus-infected pediatric patients. Pediatric Zidovudine Phase I Study Group.

McKinney RE Jr, Pizzo PA, Scott GB, Parks WP, Maha MA, Lehrman SN, Riggs M, Eddy J, Lane BA, Eppes SC, et al.

J Pediatr. 1990 Apr;116(4):640-7.

PMID:
2181102
7.

Dideoxyinosine in children with symptomatic human immunodeficiency virus infection.

Butler KM, Husson RN, Balis FM, Brouwers P, Eddy J, el-Amin D, Gress J, Hawkins M, Jarosinski P, Moss H, et al.

N Engl J Med. 1991 Jan 17;324(3):137-44.

8.

Intravenous immune globulin for the prevention of bacterial infections in children with symptomatic human immunodeficiency virus infection.

National Institute of Child Health and Human Developments Intravenous Immunoglobulin Study Group.

N Engl J Med. 1991 Jul 11;325(2):73-80.

9.

Zidovudine therapy in children with acquired immunodeficiency syndrome.

Blanche S, Caniglia M, Fischer A, Rouzioux C, Burgard M, Tardieu M, Duhamel G, Griscelli C.

Am J Med. 1988 Aug 29;85(2A):203-7.

PMID:
3165604
10.

Tuberculous meningitis in patients infected with the human immunodeficiency virus.

Berenguer J, Moreno S, Laguna F, Vicente T, Adrados M, Ortega A, González-LaHoz J, Bouza E.

N Engl J Med. 1992 Mar 5;326(10):668-72.

11.

Dideoxycytidine alone and in an alternating schedule with zidovudine in children with symptomatic human immunodeficiency virus infection.

Pizzo PA, Butler K, Balis F, Brouwers E, Hawkins M, Eddy J, Einloth M, Falloon J, Husson R, Jarosinski P, et al.

J Pediatr. 1990 Nov;117(5):799-808.

PMID:
2172501
12.

Effect of zidovudine and didanosine treatment on heart function in children infected with human immunodeficiency virus.

Domanski MJ, Sloas MM, Follmann DA, Scalise PP 3rd, Tucker EE, Egan D, Pizzo PA.

J Pediatr. 1995 Jul;127(1):137-46.

PMID:
7608800
13.
14.

Human immunodeficiency virus (HIV) antigenemia (p24) in the acquired immunodeficiency syndrome (AIDS) and the effect of treatment with zidovudine (AZT).

Jackson GG, Paul DA, Falk LA, Rubenis M, Despotes JC, Mack D, Knigge M, Emeson EE.

Ann Intern Med. 1988 Feb;108(2):175-80.

PMID:
3124680
15.
16.
17.

Combination treatment with azidothymidine and granulocyte colony-stimulating factor in children with human immunodeficiency virus infection.

Mueller BU, Jacobsen F, Butler KM, Husson RN, Lewis LL, Pizzo PA.

J Pediatr. 1992 Nov;121(5 Pt 1):797-802.

PMID:
1279153
18.

Brain growth and cognitive improvement in children with human immunodeficiency virus-induced encephalopathy after 6 months of continuous infusion zidovudine therapy.

DeCarli C, Fugate L, Falloon J, Eddy J, Katz DA, Friedland RP, Rapoport SI, Brouwers P, Pizzo PA.

J Acquir Immune Defic Syndr. 1991;4(6):585-92.

PMID:
1673712
19.

Combined therapy with recombinant granulocyte colony-stimulating factor and erythropoietin decreases hematologic toxicity from zidovudine.

Miles SA, Mitsuyasu RT, Moreno J, Baldwin G, Alton NK, Souza L, Glaspy JA.

Blood. 1991 May 15;77(10):2109-17.

20.

Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT).

Yarchoan R, Perno CF, Thomas RV, Klecker RW, Allain JP, Wills RJ, McAtee N, Fischl MA, Dubinsky R, McNeely MC, et al.

Lancet. 1988 Jan 16;1(8577):76-81.

PMID:
2891981

Supplemental Content

Support Center